Aastrom Biosciences Inc (NASDAQ:ASTM)
| 0.5084 Data as of Jun 18 |  -0.0015 / -0.29%Today’s Change | 0.49 Today|||52-Week Range 2.33 | -59.65% Year-to-Date |
Latest ASTM News | Press Releases
No recent news for Aastrom Biosciences Inc.
Today’s Trading
| Previous close | 0.51 |
| Today’s open | 0.49 |
| Day’s range | 0.49 - 0.51 |
| Volume | 222,909 |
| Average volume (3 months) | 349,885 |
| Market cap | $23.3M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -58.82% |
| Earnings growth (this year) | +42.39% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +16.67% |
| P/E ratio | NM |
| Price/Sales | 2,471.94 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADXSAdvaxis Inc | -0.00 | -2.25% |
| ELTPElite Pharmaceutical... | +0.00 | +1.03% |
| PRPHProPhase Labs Inc | +0.02 | +1.31% |
| PTNPalatin Technologies... | -0.00 | -0.16% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $21.0K |
| Annual profit (last year) | -$29.5M |
| Net profit margin | -140,352.38% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Dominick C. Colangelo |
Secretary, Treasurer, CAO & VP-Finance Brian D. Gibson, CPA |
Corporate headquarters Ann Arbor, Michigan |
Forecasts
